| Type | Sym | Class | Transaction | Value $ | Shares | Change % | * Price $ | Shares After | Date | Ownership | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|
| transaction | YMAB | Common Stock | Sale | -$1.02M | -30.7K | -0.69% | $33.19* | 4.42M | Jun 3, 2021 | By WG Biotech ApS | F1, F3 |
| transaction | YMAB | Common Stock | Sale | -$131K | -3.84K | -0.09% | $34.03* | 4.41M | Jun 4, 2021 | By WG Biotech ApS | F2, F3 |
| Id | Content |
|---|---|
| F1 | This transaction was executed in multiple trades at prices ranging from $33.165 to $34.19. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F2 | This transaction was executed in multiple trades at prices ranging from $34.00 to $34.25. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effected. |
| F3 | Reporting Person is the majority owner of WG Biotech ApS and as such has sole voting and dispositive power with respect to such shares. |